Cellcolabs vs ORGANOIDSCIENCES 오가노이드사이언스
Cellcolabs
Cellcolabs mission is to prevent and cure diseases by making high quality stem cells available and affordable
82 employees · est. 2021 · Solna, Sweden
ORGANOIDSCIENCES 오가노이드사이언스
Commercialization of the world's first organoid treatment
44 employees · est. 2018 · Korea South
ORGANOIDSCIENCES 오가노이드사이언스 is the older company (2021 vs 2018); Cellcolabs is the larger of the two.
Side-by-Side Comparison
| Metric | Cellcolabs | ORGANOIDSCIENCES 오가노이드사이언스 |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | Solna, Sweden | Korea South |
| Employees | ||
| Employees | 82 larger | 44 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series B |
| Total Funding | ||
| Total Funding | $84.70M | $26.02B |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Stem cell production, Order fulfillment for stem cells, Manufacturing process optimization, Clinical research collaboration | Not tracked yet |
| Target Customers | ||
| Target Customers | Medical researchers, Pharmaceutical companies, Healthcare professionals, Biotechnology firms | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Stem Cell ProductionIndustrial Scale ProductionDisease PreventionDisease TreatmentAffordable HealthcareMedical Research +3 | Organoid TreatmentDrug ScreeningRegenerative MedicineInnovationBio-techMedical Research +2 |
| Website | ||
| Website | cellcolabs.com | organoidrx.com |
About Cellcolabs
Cellcolabs, founded in 2021, is a pioneering company in the Biopharma, Biotechnology, Health Care, and Life Sciences sectors. Headquartered in Sweden, the company is on a mission to prevent and cure diseases by democratizing access to high-quality stem cells. Their innovative approach leverages indu...
About ORGANOIDSCIENCES 오가노이드사이언스
ORGANOIDSCIENCES is a Korean biotech startup founded in 2018 with a focus on the commercialization of the world's first organoid treatment. The company's innovative approach lies in utilizing organoid-based drug screening and regenerative medicines. With its recent $17.69M Series B investment on 13...
Also comparing in this category
Comparing more than these two?
Get Cellcolabs, ORGANOIDSCIENCES 오가노이드사이언스 and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Cellcolabs compare?
A PDF of Cellcolabs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Cellcolabs with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cellcolabs on 15 Mar 2026, and ORGANOIDSCIENCES 오가노이드사이언스 on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
